Antimicrobial Remedies and Emerging Strategies for the Treatment of Diabetic Foot Ulcers

被引:3
|
作者
Husain, Muzammil [1 ]
Agrawal, Yogeeta O. [1 ]
机构
[1] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmaceut, Shirpur 425405, Maharashtra, India
关键词
DFUs; diabetes mellitus; debridement techniques; antimicrobial peptides; diabetic neuropathy; biofilms; CLOSTRIDIAL COLLAGENASE OINTMENT; WOUND DRESSINGS; MICROBIAL LIFE; MANAGEMENT; BIOFILM; ASSOCIATION; THERAPY; PATHOGENESIS; INFECTIONS; PREVALENCE;
D O I
10.2174/1573399818666220228161608
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Diabetic foot ulcers (DFU) are one of the most serious complications in diabetic health treatment. The treatment for DFUs is more challenging, especially in individuals with a weakened immune system. Furthermore, due to developing antibiotic resistance characteristics among harmful bacteria and fungi, existing antibiotics may not be helpful in combating microbial infections in the wound site. Objective This review will focus on the newest advances in antimicrobial treatments, such as dressings and topical therapies, as well as drugs and debridement methods. Methods The English-language publications published on DFU were collected from a variety of sources, including Scopus, Web of Science, Bentham Science, Science Direct, and Google Scholar. Results DFU therapy necessitates a multidisciplinary strategy including the use of appropriate diagnostic instruments, expertise, and experience. This begins with patient education and the use of new classifications to direct care in order to avoid amputations. To gain a deeper understanding of the microbiota in DFUs, new diagnostic approaches, such as the 16S ribosomal DNA sequence in bacteria, should become usable. Conclusion DFU is said to have a polymicrobial nature and, depending on its geographical area, some distinct characteristics, such as wound characteristics, antibiograms based on local epidemiology, individualized antimicrobial driven treatment, routine debridement, regular wound examination, and dressing changes. New biological and molecular therapies that have been shown to enhance infection prevention, the management of the local inflammatory profile, and the efficiency of the cicatrizing mechanism often help with the above characteristics.
引用
收藏
页码:5 / 17
页数:13
相关论文
共 50 条
  • [41] Surgical perspective in treatment of diabetic foot ulcers
    Epstein, DA
    Corson, JD
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2001, 13 (02): : 59 - 65
  • [42] Diabetic foot ulcers - Practical treatment recommendations
    Edmonds, Michael
    DRUGS, 2006, 66 (07) : 913 - 929
  • [43] Strategy for Treatment of Infected Diabetic Foot Ulcers
    Chang, Mayland
    Nguyen, Trung T.
    ACCOUNTS OF CHEMICAL RESEARCH, 2021, 54 (05) : 1080 - 1093
  • [44] Commitment devices in the treatment of diabetic foot ulcers
    Jarl, Gustav
    JOURNAL OF FOOT AND ANKLE RESEARCH, 2019, 12 (01)
  • [45] Nanozymes for the Therapeutic Treatment of Diabetic Foot Ulcers
    Xiao, Xueqian
    Zhao, Fei
    Dubois, Davida Briana
    Liu, Qiming
    Zhang, Yu Lin
    Yao, Qunfeng
    Zhang, Guo-Jun
    Chen, Shaowei
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2024, 10 (07): : 4195 - 4226
  • [46] Growth factors in the treatment of diabetic foot ulcers
    Bennett, SP
    Griffiths, GD
    Schor, AM
    Leese, GP
    Schor, SL
    BRITISH JOURNAL OF SURGERY, 2003, 90 (02) : 133 - 146
  • [47] Commitment devices in the treatment of diabetic foot ulcers
    Gustav Jarl
    Journal of Foot and Ankle Research, 12
  • [48] Prognostic factors for treatment of diabetic foot ulcers
    Coerper, S
    Flesch, I
    Becker, HD
    Koveker, G
    EFFICIENCY AND ECONOMICS OF CLINICAL CARE AND RESEARCH IN SURGERY, 1997, SUPPL : 566 - 568
  • [49] Optimal Treatment of Infected Diabetic Foot Ulcers
    Edward B. Jude
    Philip F. Unsworth
    Drugs & Aging, 2004, 21 : 833 - 850
  • [50] Advances in the Topical Treatment of Diabetic Foot Ulcers
    Papanas, N.
    Eleftheriadou, I.
    Tentolouris, N.
    Maltezos, E.
    CURRENT DIABETES REVIEWS, 2012, 8 (03) : 209 - 218